When will Compass Pathways submit a NDA for COMP360 psilocybin?
Salud y medicinaOne-OffCienciaNegocios y empresas5d
KalshiComprobar disponibilidadKYC requeridoDatos de resolución verificadosBien calibradoPunto medio del libro seleccionado
before 2027 · —
Cargando el libro seleccionado…
—
Precio guardado
before 2027 85.5%Líder entre 6 opciones
before 2027 85.5%Calidad del mercado
52 / 100
Calidad mediaVolumen 24h
4,7 €
Interés abierto
11,9 mil US$
Interés abierto medioCompra / Venta
— / —
before 2027Spread
—
Datos de mercado
Actualizado hace 33 minutos
24 mar 26, 14:00 UTC1 nov 26, 5:00 UTC
El gráfico y los cambios muestran probabilidades históricas guardadas, no el libro seleccionado en directo.
Tendencias
Fila seleccionada: punto medio del libro. Otras filas: referencias guardadas, posiblemente normalizadas; los cambios de 24h usan el historial guardado.
before SeptemberPerdida
before OctoberPerdida
Condiciones de la plataforma
Fuente: Kalshi
Estas condiciones son informativas; las operaciones simuladas de CoinRithm siguen sus propias reglas.
- Cierre anticipado:
- Sí
- Plazo de liquidación:
- 30m (informativo)
Profundidad de mercado · before 2027
Cargando el libro seleccionado…
—
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWhen will I be able to buy cultured meat at a random Whole Foods?
Manifold MarketsWill Tomorrow Bio exist or have continuity with another organisation in 20 years?
Manifold MarketsWill 3 mg THC beverages be federally legal to sell?
KalshiWill Aurelia Song abandon Nectome before 2041?
Manifold MarketsReglas
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Reglas de cada resultado
- before 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- before April 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
- before December
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- before November
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- before September
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- before October
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
